Project Grant R21AR083025
Award Date
9/1/23
Completion Date
8/31/25
Dollars Obligated
$385K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
The University of Pittsburgh was awarded a $1,657,392 federal Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant supports research to repurpose FDA-approved drugs for the treatment of osteoarthritis (OA) using high-throughput screening in microphysiological models. The researchers will utilize three in vitro models - a cartilage model, a synovial...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $220,224 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to The Regents of the University of Colorado, operating as the University of Colorado, with a period of performance from July 4, 2024 to August 31, 2027. The funding will support the development of granular hydrogels for the controlled delivery of immunomodulatory and angiogenic extracellular vesicles to enhance...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under CFDA Program 93.846 "Arthritis, Musculoskeletal and Skin Diseases Research", provides $196,460.00 to the University of Pittsburgh to develop a novel microphysiological system for studying the role of neuro-immune interactions in osteoarthritis pain. The key objectives are to: 1) understand how inflammatory molecules from synovial-like tissue impact innervating neurons,...
This federal Project Grant award of $147,236 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports research to quantify the mechanical effects of knee bracing and predict its ability to prevent ligamentous injury. The key activities include: Determining the effects of prophylactic knee bracing on tibiofemoral kinematics in response to external loading conditions for...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $206,023 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to Cornell University to investigate mechanotransduction pathways in injured cartilage. The project aims to determine how local peak strain magnitude and manipulation of calcium-dependent signaling or mitochondrial bioenergetics affect the distribution of chondrocyte phenotypes after impact injury, using a novel...
This federal Project Grant award of $678,213 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research will fund a research project to evaluate the impact of over-constraint of the patella following medial patellofemoral ligament (MPFL) reconstruction on progressive cartilage degradation. The 4-year project aims to characterize cartilage degradation in 50 patients at least 5 years post-MPFL...
This Project Grant award for $144,362 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research to investigate the critical factors regulating the fate determination of chondrocyte progenitor cells during synovial joint and bone development. The objectives of the study are to determine: 1) the extent to which candidate transcription factors like PITX1 and ATF4...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $549,437 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The grant, effective September 1, 2024 through June 30, 2029, aims to develop a novel therapy that leverages the Hedgehog signaling pathway to improve tendon-to-bone...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to establish a detailed biophysical and biochemical understanding of enhanced cartilage formation in chondrocytes under mechanical loading. The $296,536 award to The Leland Stanford Junior University will explore how anabolic loading conditions influence the viscoelastic properties of the...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) provides $570,878 to the University of Rochester to research the modulation of myofibroblast dynamics during tendon healing. The award aims to define the efficacy of pharmacological activation of the GPR68 receptor to regulate the interaction between macrophages and myofibroblasts, which are key...